Search research articles
Contact Us
Filters
Showing results (501-510 of 558) with videos related to
Page
of 56
Sort By:
JMIR Formative Research
|
February 27, 2023
Application of Phylodynamic Tools to Inform the Public Health Response to COVID-19: Qualitative Analysis of Expert Opinions
Shannan N Rich, Veronica Richards, Carla Mavian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 3, 2006
Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results
David A Reardon, Jennifer A Quinn, Gamal Akabani, et al.
The Journal of Experimental Medicine
|
October 7, 2021
Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastrophe
Guoxin Zhang, Zhen Dong, Ryan C Gimple, et al.
Cancer Discovery
|
July 25, 2020
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies
Briana C Prager, Harish N Vasudevan, Deobrat Dixit, et al.
Nature Cell Biology
|
January 6, 2026
Inhibiting macrophage-derived lactate transport restores cGAS-STING signalling and enhances antitumour immunity in glioblastoma
Daqi Li, Gaoyuan Cui, Kailin Yang, et al.
Stem Cells (Dayton, Ohio)
|
April 17, 2014
Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression
James S Hale, Balint Otvos, Maksim Sinyuk, et al.
Neuro-Oncology
|
March 19, 2023
Sterol regulatory element-binding protein 2 maintains glioblastoma stem cells by keeping the balance between cholesterol biosynthesis and uptake
Danling Gu, Fengqi Zhou, Hao You, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma
H S Friedman, J Pluda, J A Quinn, et al.
Nature Cell Biology
|
May 22, 2026
Stress granules restrain ferroptosis by sequestering ferritin
Zehe Ge, Zihan Wang, Erjie Zhao, et al.
Cell Reports
|
November 3, 2021
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug
Junfeng Bi, Atif Khan, Jun Tang, et al.
Page
of 56
Search research articles
Search
Showing results (501-510 of 558) with videos related to
Sort By:
Page
of 56
JMIR Formative Research
|
February 27, 2023
Application of Phylodynamic Tools to Inform the Public Health Response to COVID-19: Qualitative Analysis of Expert Opinions
Shannan N Rich, Veronica Richards, Carla Mavian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 3, 2006
Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results
David A Reardon, Jennifer A Quinn, Gamal Akabani, et al.
The Journal of Experimental Medicine
|
October 7, 2021
Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastrophe
Guoxin Zhang, Zhen Dong, Ryan C Gimple, et al.
Cancer Discovery
|
July 25, 2020
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies
Briana C Prager, Harish N Vasudevan, Deobrat Dixit, et al.
Nature Cell Biology
|
January 6, 2026
Inhibiting macrophage-derived lactate transport restores cGAS-STING signalling and enhances antitumour immunity in glioblastoma
Daqi Li, Gaoyuan Cui, Kailin Yang, et al.
Stem Cells (Dayton, Ohio)
|
April 17, 2014
Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression
James S Hale, Balint Otvos, Maksim Sinyuk, et al.
Neuro-Oncology
|
March 19, 2023
Sterol regulatory element-binding protein 2 maintains glioblastoma stem cells by keeping the balance between cholesterol biosynthesis and uptake
Danling Gu, Fengqi Zhou, Hao You, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma
H S Friedman, J Pluda, J A Quinn, et al.
Nature Cell Biology
|
May 22, 2026
Stress granules restrain ferroptosis by sequestering ferritin
Zehe Ge, Zihan Wang, Erjie Zhao, et al.
Cell Reports
|
November 3, 2021
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug
Junfeng Bi, Atif Khan, Jun Tang, et al.
Page
of 56